IMV Inc. IMV Inc.

IMV Inc.

IMV

Rang în acțiuni #35070
IMV Inc. is a clinical-stage biotechnology company dedicated to the development... IMV Inc. is a clinical-stage biotechnology company dedicated to the development of innovative immunotherapies. The company utilizes its proprietary DPX immune-educating technology platform to create a portfolio of treatments for various solid and hematological cancers. Its leading investigational drug, maveropepimut-S, is a DPX-based immunotherapy designed to target cancer cells that express survivin. Maveropepimut-S is currently undergoing Phase II clinical trials for diffuse large B-cell lymphoma, ovarian cancer, and specific bladder, liver, and microsatellite instability-high tumors, with Phase I trials also active for breast cancer. Beyond its primary candidate, IMV is also advancing DPX-SurMAGE, which is in Phase I clinical trials for bladder cancer, and is developing DPX-COVID-19 and DPX-RSV to address infectious diseases. Originally founded in 2000 as Immunovaccine Inc., the company adopted the name IMV Inc. in May 2018 and operates from its headquarters in Dartmouth, Canada.
Preț acțiune
$0.82959892
Ultima sincronizare: 2023-05-23
Capitalizare de piață
$4.16M
Schimbare (1 zi)
-0.04%
Schimbare (1 an)
82,959,792.06%
Țară
CA
Tranzacționează IMV Inc. (IMV)

Categorie

Healthcare
Istoric al prețului acțiunii pentru IMV Inc. (IMV)
Cel mai mare preț de închidere: $0.00 pe 2024-04-01

Cel mai mic preț de închidere: $2.79 pe 2009-10-01
Istoric al prețului acțiunii pentru IMV Inc. din 2009 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2024 -99.62%
2023 -99.90%
2022 -80.41%
2021 -58.37%
2020 14.77%
2019 -48.18%
2018 1.97%
2017 209.96%
2016 -4.32%
2015 -11.63%
2014 46.23%
2013 3.39%
2012 10.27%
2011 -50.45%
2010 -42.36%
2009 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$527.18 23.62%
US
$251.29 835.90%
US
$137.83 -3.78%
AU
$890.85 9.42%
NL
$764.76 8.70%
CH